PRedicting the population health economic IMpact of current and new CAncer Treatments (PRIMCAT)

Abstract

Professor Maarten IJzerman, together with colleagues in the University of Melbourne, the University of New South Wales, Peter MacCallum Cancer Centre and the Walter and Eliza Hall Institute have been awarded more than $2.3 million for their proposal “PRedicting the population health economic IMpact of new CAncer Treatments” (PRIMCAT).

PRIMCAT addresses a health policy concern raised by the Pharmaceutical Benefits Advisory Committee (PBAC), the Medical Services Advisory Committee (MSAC) and the Medical Research Future Fund (MRFF) about the uncertainties in the projected number of patients receiving treatment at different stages over the next 5 years for three nominated cancers, in..